1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Refractory Neoplasm: new trials by email Literature Review of Refractory Neoplasm trials Research Report on Refractory Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers Laboratory Biomarker Analysis, Metformin, Pharmacological Study - Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1 | Completed | M.D. Anderson Cancer Center | 31 | 2018-03-12 | 2023-10-04 |
Neoplasm Metastasis (1) · Neoplasms (1)
Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Metformin (1) · sapanisertib (1)
M.D. Anderson Cancer Center (1)
United States (1)
Vivek Subbiah (1)
P30CA016672 (1)